Wells Fargo lowers Biogen (NASDAQ:BIIB) price target from $350 to $343

By / / Biogen, Wells Fargo

Wells Fargo analyst Mohit Bansal maintains Biogen (NASDAQ:BIIB) with a Overweight and lowers the price target from $350 to $343.

Scroll to Top